Good news from stem cell pioneer and cardiologist Zannos Grekos
From the onset it was clear that a conversation with Doctor Zannos Grekos would not be purely medical or academical. The Greek-American Clinical Professor of Cardiology at NOVA Southeastern University in Florida’s Fort Lauderdale, USA, has in recent years been progressing the treatment of heart, pulmonary and circulatory diseases with stem cells. Hotly debated and awaiting approval from most national regulating agencies, stem cell therapy for many still constitutes a medical grey zone. However, whereas no treatment has yet been undertaken with Embryonic stem cells, the root of most concerns, Grekos has already made great therapeutical strides using a patient’s own Adult Stem Cells to regenerate damaged, even dead human nerves, tissue and organs. Invited to Athens by Anti-aging specialist Kostas Koutoudis, Zannos Grekos gave two eye-opening dialexeis about developments in stem cell therapy, in impeccable greek, to medical university students and clinical staff at the Metropolitan Hospital. In an exclusive interview with L’Officiel Hommes he talks about the positive impact adult stem cell treatment is having on patients with heart and circulatory complications, and its potential for helping incurable conditions like stroke, dementia and cancer.
When did you get involved with adult stem cell treatment?
It was serendipity. I heard about it first when a friend of mine left for Thailand in 2006 to have stem cell therapy, and seeing the potential it could have in cardiovascular treatment I became entirely submerged in its capabilities. You try to keep your head above water and go in the right direction.
In your presentation you showed cases where patients injected with their own adult stem cells showed signs of regenerated tissue, in the case of the American Football player whose limbs had become mummified due to necrotizing meningitis, and grown new blood vessels in legs with vascular circulation problems in a matter of months. How do you go about this procedure?
The process begins with a complete medical evaluation to determine the patient’s medical status and qualification for therapy. Once testing is complete, we draw 300cc of the patient’s blood, from which peripheral blood stem cells are extracted. The very few naturally occurring stem cells in the blood sample are then cultivated and multiplied. They are then injected back into the patient’s target organ. Since it is the patient’s own stem cells, there is no possibility of rejection.
How can stem cells be trained to regenerate an affected part of the body?
Using naturally occurring growth factors that we have in our bodies. So If we want the stem cell to become and promote blood vessels, we multiply it and differentiate it with Vascular Endothelial Growth Factors (VEGF), that’s a growth factor that our own bodies produce. When somebody has a blockage in their artery of their heart and the body naturally wants to develop collaterals, or natural bypasses, there’s a higher concentration of VEGF that’s produced in that area, and the body will generate new blood vessels. The problem is that when you have a huge heart attack, the amount of VEGF that is produced is not enough to overcome all the damage and you progress towards congestive heart failure. All we are doing is taking the natural repair systems that the body has in place and augmenting them, amplifying them, and then redelivering them to the area of damage.
You are also Director of Cardiology and Vascular Disease at Regenocyte, the first US-based regenerative cell therapy clinic that is actively treating patients with Adult Stem Cells. What are the risks involved with such therapies?
Regenocyte therapy, derived from the Latin terms ‘regeneratus’ (created again) and ‘cyte’ meaning cell, is the commercial-coined term of utilizing expanded and partially differentiated cells. It conveys the difference between a stem cell that has not been activated and/or differentiated towards the organ system that we’re looking to repair, which carries therapeutic advantages. We have never seen an untoward or negative side effect from the stem cells themselves. The risks are all secondary to the procedure that is utilized to implant the stem cells. For instance, if the cells are being injected with a hypodermic needle directly into the calf muscle, then there’s only the theoretical risk of infection and such involved with those 30 or so injections. But really it’s an extremely non-risky procedure. The risks associated with delivering the stem cells to the heart is similar to a cardiac catheterization. The sicker the patient or the older the patient, the higher the risk, but it’s still in the less than 1-2% complication rate with a 1-in-8,000 to 1-in-15,000 death rate.
Are you applying established vascular intervention techniques?
Yes, we’re using very similar catheters used in a technique on a regular basis daily throughout the world. There’s an injection catheter that we use to inject into the myocardium, and that’s been looked at in several clinical trials in Europe and in the U.S. which has a very good safety record. The procedures of the catheter carry very little difference from putting in a pacemaker wire, the risks are parallel with those of injecting stem cells into the heart.
How could you minimize even these risks?
I believe that in the future we will become better and better at delivering stem cells to the area of damage. That may be nano technology, it may be the utilization of magnetic carriers that can be focussed using an external magnetic beam, it may be receptor-specific where we place receptors on these cells that will be attracted to specific organ receptors. The technology is out there, it’s just a matter of applying it to the therapy that we’re talking about. And of course the greater volume that an operator has with delivery of the stem cells, the lower the risk comes from the delivery, like any surgical procedure. In Medicine any procedure always carries some degree of risk because humans are not engineered machines that are exactly the same one to the other. You need a physician that is an artist at the same time that knows how to utilize the technology that he has to achieve the best result in that individual patient. A doctor never stops learning
Does the art also lie in a holistic approach of talking to the patients, knowing what their symptoms are and applying your acquired knowledge of stem cells with the tools at your disposal to achieve the best result?
That is absolutely correct, and interestingly enough there’s a concept that is recently becoming popular called Personalised Medicine, where we look at the patient as an individual and personalise the treatment for that patient. What I find interesting is that it’s being hailed as a new concept, and yet that’s the way medicine used to be. The doctor would spend time with the patient and found and potentially compounded the right medication or treatment for that individual patient. It all started in Ancient Greece, and we’ve come away from that and de-personalised medicine which I believe has been a disservice to society.
Why do you think that happened, was it because of the corporatisation of medicine and pharmaceuticals?
Absolutely. Especially in the United States when health care management came into play and we took away the luxury that the physicians had, which was time to spend with the patient, and forced them to see many patients in a day.
What are your views on President Obama’s new bill for government-paid universal healthcare?
How it was initially crafted and how it will eventually end up is something that we will get to see, because it has gone through several iterations. It’s interesting that I speak to healthcare professionals who are upset that Illegal immigrants will be covered by the new healthcare plan, and I look at them and wonder “this was the same person who was complaining two days ago that they were not getting paid for taking care of an illegal alien in the US.” Now, because of political ideation or “brainwashing” they’re defeating the same bill that’s supposed to reimburse them for something they were complaining about just recently. But I’m not very involved with the politics of the healthcare plan.
Could we train our own stem cells to be healthier?
Of course, we do this in medicine all the time. When I have a patient who has poor circulation to their legs, I tell them to walk, and what does walking do? It induces new vasculature. So there are things that we can do in our daily lives to train ourselves, that’s why exercise is good thing. Exercise is not an arbitrary recommendation by physicians. For the most part we don’t even know why it is good for us, but as we get to know stem cells better we understand that exercise induces increased circulating stem cells which in turn slows the aging process. People that die in their 100s have much higher circulating stem cells than people that die at a younger age. Now whether that’s genetic or whether it’s induced by activity and exercise, that I don’t know, but there are certain things that we know will lengthen longevity and increase the quality of life of the patient.
In the history of life on earth, the presence of mankind has taken up merely a speck of time. What are the benefits of prolonging a human life a fraction of its natural course?
We’re not just hoping to help people live longer, we want them to live better and happier, and many times that’s what we achieve with the stem cell treatments for these patients. We take them from becoming cardiac cripples where they can barely get off the couch to being to do things in their life. I’ve had patients we treated, we gave them a very good year in life and at the end of that year they died, suddenly. But up until then they were traveling to Europe, they were going on cruises, they were doing all kinds of things that before they couldn’t. And the family was very grateful, as was the patient before passing away, that we were able to improve their quality of life. A lot of patients that we treat have said: “If I die tomorrow, I’ll be happy, because I got two or three years of good quality rather than a slow deterioration sitting on a couch not being able to move.”
Sitting with us at lunch, Kostas Koutoudis joins in the conversation.
K.K.: Δεν προσπαθούμε να παρατείνομε ανώμαλα τη ζωή ένας ανθρώπου. Δεν υπάρχει κάτι διαβολικό μέσα σ' αυτό. Σε αυτή την φάση προσπαθούμε να ικανοποιήσουμε αυτό το potential που μας έδωσε ίδια η ζωή. Η ίδια η ζωή μέσα τον γονιδίων και τον χρωματοσωμάτων έχει δώσει ένα δυναμικό ζωή σε ένα άτομω. Το μομέντουμ είναι περίπου για 125-130 χρόνια, όλη οι υπολογισμοί συμφωνούν σε αυτό, βιοχημική και φυσική υπολογισμοί, και οι άνθρωποι πεθαίνουν 80 ετών. Οι άνθρωποι πεθαίνουν πρόωρα. In a way we are satisfying evolution’s wish.
Z.G. Our basic natural role is to perpetuate, so from a biological point of view our primary task is done by the time we are 35. However, if we truly believe that we are on this earth to live a good life and enjoy our life, we are reaching the potential of what that life ought to be. So we’re extending the ability to enjoy the quality of life, and if we happen to extend life itself, then that’s an added benefit. There are two kinds of people, the ones who fear death and those who don’t want to leave life. The ones who are afraid to die are miserable. Those who like their life wouldn’t mind if they died tomorrow, they are happy now. If with stem cell therapies we can reduce or even eliminate the suffering associated with the top five terminal diseases, prostate cancer, colon cancer, heart attack, stroke and breast cancer, I think people will be able to live much more peacefully.
This article was first published in the spring 2010 edition of L’Officiel Hommes Hellas
© Marq Riley



